FDA Inspection 919466 — Blistex Inc

Blistex Inc — FEI 1413077

The FDA completed an inspection of Blistex Inc on Mar 26, 2015 in Oak Brook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 26, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Over-the-Counter Drug Evaluation
Location
Oak Brook, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.